TP53 and ovarian cancer: In the present study, cancer cells from 7 of totally 10 patients had TP53 missense mutations in the DNA binding region, two carried nonsense mutations, and one sample had wild type TP53. Two of the mutations have not previously been reported in ovarian cancer (L111Q and E346*).